← Back
$APLS All transactions

Apellis Pharmaceuticals, Inc.

A

$ Value

$0

Shares

6,250

Price

$0

Filed

Jun 20

Insider

Name

Chopas James George

Title

VP/Chief Accounting Officer

CIK

0001836430

Roles

Officer

Transaction Details

Transaction Date

2025-06-18

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

54,205

Footnotes

This restricted stock unit was granted on June 18, 2025. The restricted stock unit will vest over a two-year period. Specifically, 50% of the restricted unit will vest on each of the one-year and two-year anniversaries of the grant date, contingent upon continued service.

Filing Info

Accession No.

0001127602-25-017836

Form Type

4

Issuer CIK

0001492422

Chopas James George's History

Date Ticker Type Value
2026-01-28 APLS A $0
2026-01-22 APLS $45K
2026-01-20 APLS $14K
2026-01-13 APLS $19K
2025-09-15 APLS $5K
2025-09-02 APLS $15K
2025-06-18 APLS A $0
2025-06-09 APLS A $218K

Other Insiders at APLS (90d)

Insider Bought Sold Last
Dolsten Mikael 2026-02-27
Watson David O.
General Counsel
2026-01-28
Deschatelets Pascal
Chief Scientific Officer
2026-01-28
Francois Cedric
Chief Executive Officer
2026-03-11
Sullivan Timothy Eugene
Chief Financial Officer
2026-04-17
O'Brien Stephanie Monaghan 2026-04-06
Nicholson Nur
Chief Technical Officer
2026-01-28
Chopas James George
VP/Chief Accounting Officer
2026-01-28
DeLong Mark Jeffrey
Chief Business & Strat Officer
$8K 2026-02-11
Boucher Kelley
Chief People Officer
2026-01-28
MELTZER LESLIE
Chief Research and Development
2026-01-28